AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Aug 30 2023
News
Biden vs. Big Pharma: Medicare to Begin Price Negotiations on Costly Drugs & Insulin
The Biden administration has taken a major step to rein in price gouging for prescription drugs in the United States. Medicare will now be able to negotiate prices on 10 of the most expensive drugs used to treat diabetes, cancer, heart disease and more. That list is set to expand over the years. In what’s seen as a blow to Big Pharma, the White House says the move, a part of the Inflation
Democracy Now!
Aug 29 2023
News
Biden Administration Adds Insulin to Drug Price Negotiation List in Major Blow to Big Pharma
pleasantly stunned health care reform advocates Tuesday by including short-acting insulin in its list of 10 drugs for which Medicare will negotiate lower prices, power vested in the White House by the Inflation Reduction Act. The IRA was passed in the face of one of the heftiest barrages of lobbying in congressional history, with the pharmaceutical industry spending more than $700 million over
The Intercept
Aug 16 2020
News
Big Pharma’s Covid-19 Profiteers
On June 29th, 2020, while America remained transfixed by anti-police protests, the chairman and CEO of the pharmaceutical company Gilead issued a much-anticipated announcement. In a breezy open letter, Daniel O’Day explained how much his company planned on charging for a course of remdesivir, one of many possible treatments for Covid-19. “In the weeks since we learned of remdesivir’s potential
RollingStone.com
May 12 2018
News
Big Pharma Gets a Big Win From Trump
The president campaigned on stinging criticisms of the pharmaceutical industry and promises to use Medicare to lower drug prices. But none of that materialized in his drug-pricing speech this week.
The Atlantic
Aug 31 2023
Analysis
Watchdog Says Elizabeth Warren Being Fooled By ‘Bogus’ Pledge From Biden Nominee On Big Pharma Payments
A watchdog group has raised a red flag over a promise — from President Joe Biden’s choice to head up the National Institute of Health — to not take any money or work for a Big Pharma company for four years after leaving her position.
Monica Bertagnolli, Biden’s pick to head up the NIH, made the promise in a letter sent earlier this month to Massachusetts Senator Elizabeth Warren. The
The Daily Wire
Nov 30 2023
News
No. 15 Creighton uses big first half to defeat Oklahoma State in Big East/Big 12 Challenge
STILLWATER, Okla. — Ryan Kalkbrenner had the matchup he wanted, and he made sure Trey Alexander knew it. A wave of the senior’s outstretched arm let everyone in Gallagher-Iba Arena know it. Seconds later, Creighton men’s basketball’s 7-foot-1 center palmed Alexander’s entry pass, rose over Oklahoma State freshman Brandon Garrison and threw it down for a bucket — and a spark — the No. 15
Omaha World-Herald
Dec 01 2023
News
No. 5 Kansas outlasts No. 4 UConn in Big East/Big 12 Battle
LAWRENCE, Kan. (WIBW) - Kevin McCullar Jr. shot lights out down the stretch to help push Kansas and defeat the defending national champs, 69-65. KU started hot jumping out to a 15-6 lead after a Hunter Dickinson three pointer and it stayed that way most of the first half, leading 28-18 after a KJ Adams Jr jump shot. The Huskies stuck around thanks to Tristen Newton, making several from
WIBW 13
Jan 28 2023
Opinion
If you really want to understand how powerful Big Pharma is, consider this
How powerful exactly are the big pharmaceutical companies in this country? Well, that's a big question. There are a lot of ways to measure it, but here are a few ways you can measure it. In this country, Big Pharma can advertise its drugs directly to consumers and that's a little strange if you think about it, since consumers don't prescribe drugs, doctors do. So, why are the drugs being
Tucker Carlson
Oct 22 2023
News
Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel.
Swiss health care company Roche announced it would acquire Telavant Holdings Monday, in a deal worth $7.1 billion.
Telavant creates drugs for people suffering from inflammatory and fibrotic diseases, and is in the process of developing a "promising new therapy" for patients with Crohn's disease, Roche said in
CNBC
Nov 30 2023
News
Henry Kissinger, dead, is big on LinkedIn
Henry Kissinger’s death at 100 on Wednesday, after a storied career drenched in blood and unchecked war crimes, has sparked both dutiful tributes and notes of justified revulsion from around the world. But in one corner of the internet, merchants of corporate aspiration have been activated, celebrating what appear to be random encounters with the former secretary of state. The apparent purpose
Mother Jones